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Background Spontaneous coronary artery dissection (SCAD) is an underestimated cause of acute coronary syndromes. A predisposing
arteriopathy is often present and a stressor can sometimes be identified. Autosomal dominant polycystic kidney disease
(ADPKD) is the most common hereditary kidney disorder; its associated arteriopathy has been described as a predispos-
ing condition for SCAD.
...............................................................................................................................................................................................................
Case summary A 44-year-old woman with ADPKD presented in the emergency room with recent onset thoracic pain radiating to the left
arm at rest. She had undergone a recent liver transplant, for which she had received high-dose corticosteroids during 1 month.
She was still taking tacrolimus and mycophenolate mofetil. She had no traditional risk factors but had experienced stress post-
operatively. She was known with moderate chronic kidney disease. The initial electrocardiogram (ECG) was normal but high-
sensitive troponin T was significantly elevated. Coronary angiography demonstrated diffuse narrowing of the distal left anterior
descending artery with preserved flow, compatible with a SCAD Type 2 that was treated conservatively. However, under dual
antiplatelet therapy (DAPT) with clopidogrel, the coronary dissection was progressive with new ischaemic ECG changes, fur-
ther rise of troponins and development of apicoseptal hypokinesia. Because of the small vessel diameter and the preserved dis-
tal flow, conservative treatment was maintained. Clopidogrel was interrupted and the patient remained stable.
...............................................................................................................................................................................................................
Discussion As SCAD remains an underestimated cause of myocardial infarction, clinicians should be aware of the possibility of SCAD
in ADPKD patients with chest pain. This case report illustrates that the decision DAPT vs. aspirin should be individualized
in these patients.
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Learning points
• Spontaneous coronary artery dissection (SCAD) patients often have little or no traditional cardiovascular risk factors.
• Autosomal dominant polycystic kidney disease associated arteriopathy can predispose to SCAD.
• Corticosteroids can trigger the event.
• Treatment of SCAD is usually conservative because of the high probability of spontaneous healing, while intervention is reserved for cases
with high-risk features like left main dissection, ongoing ischaemia, electrical, or haemodynamic instability.
• Prolonged inpatient monitoring (5–7days) is recommended because of the risk of progression of the dissection.
• The need for dual antiplatelet therapy should be carefully evaluated in conservatively treated SCAD patients.
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Introduction
Spontaneous coronary artery dissection (SCAD) is defined as a spon-
taneous (non-traumatic, non-iatrogenic, and non-atherosclerotic) sep-
aration of the coronary artery wall by intramural haemorrhage
resulting in myocardial ischaemia. It is elicited by an intimal tear or a
spontaneous intramural haemorrhage. Patients can present with the
whole spectrum of acute coronary syndromes (ACS). The prevalence
in the general population has been underestimated as a result of under-
diagnosis. Recently, the condition is gaining recognition and recent
angiographic data report an incidence of SCAD in 1–4% of patients
presenting with ACS.1,2 The aetiology of SCAD appears to be multifac-
torial but patients often have a predisposing condition and, in many
cases, a precipitating trigger is recognized. Predisposing conditions in-
clude heritable connective tissue disorders, fibromuscular dysplasia,
systemic inflammatory disease, and pregnancy-related hormonal
changes, as they can cause weakening of the arterial wall. Emotional
and extreme physical stress have been described as possible triggers,
while hormonal therapy and corticosteroids have been identified as
both predisposing factors and precipitating triggers (see Table 1).3
Autosomal dominant polycystic kidney disease (ADPKD) is the
most common hereditary kidney disorder. It is caused by mutations
in PKD1 and -2 genes, coding for polycystin 1 and 2, proteins with an
important role in the development and maintenance of the vascular
system.4 Cystic malformation leads to progressive loss of kidney
function over decades.4,5 It is a systemic disorder with polycystic liver
disease being the most common extrarenal manifestation.4
Intracranial aneurysms are the most common vascular manifest-
ation.5 Common cardiac manifestations include mitral valve prolapse
and aortic insufficiency.4
Timeline
Case presentation
A 44-year-old woman was referred by her gastrointestinal surgeon
to the emergency room (ER) because of multiple episodes of chest
pain. She was, like her mother, known with ADPKD as well as poly-
cystic liver disease, without (intracranial) aneurysms. Two months
earlier, a liver transplantation had been performed because of dys-
pnoea caused by the liver cysts. She was under treatment with antire-
jection medication (tacrolimus, mycophenolate mofetil, and steroids
that were tapered recently). She did not smoke and there were no
other cardiovascular risk factors but stress. The chest pain started
....................................................................................................................................................................................................................
Day Events
1 Consultation abdominal surgery after recent liver transplant: complaints of intermittent chest pain, cardiological workup planned.
4 Admission to the emergency room: persisting heavy chest pain.
Electrocardiogram (ECG) showed a normal sinus rhythm without ST segment or T-wave abnormalities.
Blood samples revealed elevated cardiac troponins T (53 pg/mL) but without evolution.
Transthoracic echocardiogram (TTE) showed a non-dilated ventricle wild mild septal hypertrophy, normal regional, and global left ventricular
function without significant valvulopathy.
Coronary angiography was performed and showed a diffuse stenosis of the distal left anterior descending artery (LAD) compatible with a spon-
taneous coronary artery dissection. Conservative treatment with dual antiplatelet therapy, low-dose statin, and beta-blocker was started.
The patient was admitted to the intensive cardiac care unit for further evaluation.
6 New episode of chest pain: ECG showed diffuse ST segment and repolarization abnormalities.
A new TTE showed apicoseptal hypokinesia.
A new coronary angiography showed a more proximal and prominent dissection of the LAD (75–95% stenosis) with preserved distal flow. No
percutaneous coronary intervention because of small vessel size.
Transdermal nitrates were associated, clopidogrel was interrupted and a small dose of angiotensin-converting-enzyme inhibition was initiated.
Afterwards, the patient remained pain free.
7 Prolonged monitoring reveals a single asymptomatic episode of non-sustained ventricular tachycardia.
10 Discharge under medical treatment with close follow-up.
33 Follow-up outpatient visit, no problems. Initiation of cardiac rehabilitation.
..................................................................................................
Table 1 Possible predisposing conditions and triggers
for spontaneous coronary artery dissection
Case patient
Known predisposing
conditions for SCAD
Inherited arteriopathy and
connective tissue disorder
ADPKD
Systemic inflammatory disease No evidence
Fibromuscular dysplasia No evidence
Exogenous hormones Was recently on high-dose steroid
therapy (tapered 1 month before)
Pregnancy and multiparity No (recent) pregnancy, one daughter
Known triggers for SCAD
Extreme emotional stress Present
Intense exercise Not recent
Active hormonal therapy Was recently on high-dose steroid
therapy (tapered 1 month before)
Recreational drugs None
2 E. Verlaeckt et al.
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during sleep, radiated to the left arm and subsided spontaneously
after 5min. The electrocardiogram (ECG) in the ER showed a normal
sinus rhythm without ST segment or T-wave abnormalities. Patient
was afebrile, with a blood pressure of 137/74mmHg and a regular
pulse of 77 b.p.m. On auscultation heart sounds were normal and
lungs were clear. There was no peripheral oedema and peripheral
pulsations were normal. Chest X-ray was normal. Blood samples
showed a chronic but stable kidney disease (eGFR 36mL/min/
1.73m2), absence of inflammation or anaemia. High-sensitive tropo-
nin T-level was significantly elevated (53 pg/mL) but showed no sig-
nificant evolution after 3 h. A transthoracic echocardiogram (TTE)
demonstrated a non-dilated ventricle (end-diastolic diameter 41mm)
with mild septal hypertrophy (14mm), normal regional contractility,
a preserved left ventricular (LV) systolic function and absence of sig-
nificant valvulopathy. A coronary angiography was performed and
showed diffuse narrowing of the distal left anterior descending artery
(LAD) with ‘stick insect’ aspect, compatible with a SCAD Type 2
with preserved distal flow6 (Figure 1). The patient was admitted to
the intensive cardiac care unit for further observation and treatment.
Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin was
started, as well as pravastatin and a low dose of bisoprolol. During
the following days, the troponin level steadily rose with stable kidney
function. Three days later, chest pain redeveloped for which IV
nitrates were associated but these were quickly interrupted because
of headache. The ECG was progressively abnormal with diffuse bi-
phasic T waves in the anterior leads (V2–5). A repeat TTE now
showed apicoseptal hypokinesia. A new coronary angiography
showed a more proximal and prominent dissection of the mid and
distal LAD (75–95% stenosis), with preserved distal flow (Figure 2).
Transdermal nitrates were associated after which the pain subsided.
Clopidogrel was interrupted because of the progression under
DAPT and a small dose of angiotensin-converting-enzyme (ACE)-
inhibition was initiated because of the depressed LV function.
Prolonged monitoring revealed a single episode of non-sustained
ventricular tachycardia. The patient remained asymptomatic and the
rest of the stay was uneventful. She was discharged after 10days and
was still doing well at follow-up after 1month with cardiac enzymes
that returned to baseline levels. Cardiac rehabilitation, including psy-
chological support, was initiated.
Discussion
We report a SCAD in an ADPKD patient, an association of which
only eight cases have been described in the literature.7,8 A recent
nationwide retrospective analysis of 66 360 SCAD cases, however,
identified 60 patients (0.09%) with ADPKD.9 The association
between SCAD and inherited arteriopathy and connective tissue
disorder is known.1–3 Autosomal dominant polycystic kidney
disease is a known predisposing factor for vascular abnormalities,
especially cerebral aneurysms.4 Our patient did not have intracra-
nial aneurysms or vascular abnormalities in the thorax or abdo-
men. The recent treatment with corticosteroids and the
associated stress may have triggered the SCAD and to our know-
ledge, this is the first case of SCAD in a recently transplanted
ADPKD patient.
Most (>90%) SCAD patients are women and typically have a low
cardiovascular risk profile, which may cause delayed diagnosis.1,3
However, thanks to increasing awareness and the introduction of
high-sensitive troponins diagnosis has improved.10
The management of SCAD differs from that of atherosclerotic
coronary artery disease.1–3 In our case, no other classical risk factors
but chronic kidney disease and emotional stress were identified. She
was on steroid antirejection therapy the month before, which is a
possible precipitating factor for SCAD.1–3
Figure 1 Coronary angiogram Day 0: apical 0 , cranial 35 dem-
onstrating diffuse stenosis of the mid and distal LAD with ‘stick in-
sect’ aspect (arrows).
Figure 2 Coronary angiogram Day 4: apical 0, cranial 38 dem-
onstrating more proximal and prominent dissection (arrow).
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.Coronary angiography is the gold standard for the diagnosis of
SCAD with intracoronary imaging (optical coherence tomography
or intravascular ultrasound) being preserved for uncertain diagno-
sis. The commonly used angiographic classification consists of three
types. Type 1 represents the pathognomonic form with multiple
radiolucent lumens and extraluminal contrast staining. Type 2, the
commonest type, refers to a diffuse stenosis of varying length (usu-
ally >20 mm), while a Type 3 SCAD is a focal or tubular and usual-
ly short (<20 mm) stenosis that mimics atherosclerosis. In addition,
a Type 4 presentation characterized by a total occlusion, usually of
a distal vessel is described in the European position paper on
SCAD.1 Some familiarity with these angiographic appearances is
needed to recognize SCAD but further intracoronary imaging can
be necessary, especially in Type 3 presentations. The LAD is the
most affected vessel and there is a predisposition for distal seg-
ments, as seen in this case.1,3
There is increasing evidence of angiographic healing with medical
treatment and percutaneous intervention is associated with a high
complication rate.11 Therefore, medical treatment is preferred over
revascularization in case of preserved flow and absence of high-risk
features like left main dissection, ongoing ischaemia, electrical, or
haemodynamic instability.1–3,12 In this case, angina was controlled
medically, furthermore, percutaneous intervention was not possible
because of the small size of the vessel.
There is little evidence for medical treatment of SCAD, current
recommendations are based upon expert opinion. Dual antiplatelet
therapy with aspirin and clopidogrel was started in this case, as rec-
ommended by most experts (1–12months) because of evidence that
high-grade stenosis can be associated with true luminal thrombus in
SCAD patients. However, in contrast with a classic ACS, clopidogrel
is preferred over newer P2Y12 inhibitors like ticagrelor and prasugrel
because of lack of data and their higher associated bleeding risk.
Here, clopidogrel was interrupted because of the progression of the
dissection, indicating that the need for DAPT should be evaluated on
a patient by patient basis. Given the LV impairment, beta-blockers,
and ACE-inhibitors were indicated in this patient.1–3 Statins are not
routinely recommended since the aetiology of SCAD is not athero-
sclerotic. Furthermore, a small retrospective cohort demonstrated a
higher recurrence rate in statin users, therefore, their use should be
reserved for patients with conventional indications for statins.1–3
In 5–10% of SCAD patients on medical treatment, extension of
dissection occurs in the early phase, as in our case. Therefore pro-
longed inpatient monitoring (5–7days) is recommended in SCAD
patients.1–3 Despite a favourable 30days survival, 30-day major ad-
verse cardiovascular events rate is high (9%).2,13
Recurrent SCAD can complicate the long-term course and has
been reported to be as high as 30% in older series. Unfortunately,
there is no treatment strategy that has shown to reduce this risk. In a
recent prospective cohort study, this risk was substantially lower
(10.4% over a 3-year time course), and therapy with beta-blockade
seemed to reduce recurrence risk, probably by lowering the coron-
ary arterial wall stress through decrease in myocardial contractility
and blood pressure.14
It is very important to acknowledge the impact of SCAD on psy-
chological well-being. Rates of depression and anxiety in SCAD
patients are similar to those of non-SCAD myocardial infarction
patients.15 Therefore, specific rehabilitation programmes including
psychological support are strongly recommended.16 Patient groups
active on social media, such as Beat SCAD-UK and SCAD Alliance,
aim to support SCAD patients and their families and raise awareness
of SCAD.
Conclusion
Autosomal dominant polycystic kidney disease associated arteriopa-
thy predisposes to SCAD and high doses of corticosteroids, given in
the transplant setting, may trigger the event. Caregivers should be
aware of this association when evaluating ADPKD patients with chest
pain. Most cases can be managed conservatively with medical man-
agement. Dual antiplatelet therapy with aspirin and clopidogrel is rec-
ommended by experts but should be evaluated on an individual basis.
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